Ignite Creation Date:
2025-12-24 @ 12:37 PM
Ignite Modification Date:
2026-03-12 @ 3:08 PM
Study NCT ID:
NCT03097861
Status:
COMPLETED
Last Update Posted:
2020-01-14
First Post:
2017-03-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo
Sponsor:
Sucampo Pharma Americas, LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SCMP-0211-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None